Status:
UNKNOWN
NHF vs. COT in Hypoxemic Pandemic Viral Illness
Lead Sponsor:
Jens Bräunlich
Conditions:
Acute Viral Bronchitis
Hypoxemic Respiratory Failure
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The study compares oxygen and NHF in patients with acute viral illness. The duration will be 72h. After them physiological parameters and the outcome will be evaluated.
Eligibility Criteria
Inclusion
- acute hyperemic viral illness
- acute hyperemic or hypercapnia respiratory failure
Exclusion
- intubation criteria
- indication for NIV therapy
- influences of primary endpoint (rip fracture, lung embolism)
- tracheostomy
- other interventional trials
- noncompliance
Key Trial Info
Start Date :
January 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 22 2022
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04750408
Start Date
January 22 2021
End Date
June 22 2022
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum Emden
Emden, Germany, 26721